Skip to main content

Advertisement

Table 1 Patient and disease characteristics

From: Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

Characteristic  
Age (years) (median, range) 55 (37–62)
Gender
 Male 2 (18.2 %)
 Female 9 (81.8 %)
ECOG performance status at diagnosis
 0 7 (63.6 %)
 1 4 (36.4 %)
Primary tumor site
 Pleura 5 (45.5 %)
 Abdomen 2 (18.2 %)
 Pelvis 2 (18.2 %)
 Ovary 1 (9.1 %)
 Upper limb 1 (9.1 %)
Pathological characteristics at diagnosis
 Mitotic index (/10 HPFa) (median, range) 9 (3–30)
Necrosis
 No 6 (54.5 %)
 Yes 5 (45.5 %)
 <50 % 3
 >50 % 0
 Unknown 2
 Tumor size (mm) (median, range) 145 (45–180)
Tumor classification at diagnosis
 Benign 1 (9.1 %)
 Malignant 10 (90.9 %)
 Stage of disease at diagnosis  
 Local 9 (81.8 %)
 Metastatic 2 (18.2 %)
  1. a/10 high-power fields